Research
Hormonal
GLP-1 receptor agonists (GLP-1 RAs) produce significant weight loss (7–24%) and HbA1c reductions (1.5–2.0%) through pleiotropic mechanisms including enhanced mitochondrial function, anti-inflammatory actions, and improved cellular quality control.
GLP-1 medications are highly effective for weight loss and blood sugar control. They work through multiple biological pathways, not just hunger suppression. Newer oral versions exist for those who prefer pills over injections. Consult a doctor to determine the right agent and dose for your specific health profile.
StrongSupportsHIGH confidence
GLP-1 RAs demonstrate pleiotropic effects through fundamental cellular mechanisms, including enhanced mitochondrial function, anti-inflammatory actions, improved cellular quality control, and comprehensive metabolic regulation. Established applications demonstrate robust efficacy in diabetes management (HbA1c reductions of 1.5–2.0%), obesity treatment (weight loss of 7–24%)...
Why this rating
The paper is a comprehensive systematic review synthesizing evidence from multiple large-scale clinical trials and meta-analyses.
Source
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)
Shikha Patel et al. · Pharmaceutics · 2025
Meta-analysisCited 14×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →